Exprivia SpA
MIL:XPR
Intrinsic Value
The intrinsic value of one XPR stock under the Base Case scenario is 3.46 EUR. Compared to the current market price of 1.52 EUR, Exprivia SpA is Undervalued by 56%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Exprivia SpA
Fundamental Analysis

Revenue & Expenses Breakdown
Exprivia SpA
Balance Sheet Decomposition
Exprivia SpA
Current Assets | 126m |
Cash & Short-Term Investments | 24.1m |
Receivables | 69.4m |
Other Current Assets | 32.5m |
Non-Current Assets | 97.4m |
Long-Term Investments | 1.2m |
PP&E | 17.4m |
Intangibles | 76.4m |
Other Non-Current Assets | 2.3m |
Free Cash Flow Analysis
Exprivia SpA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Exprivia SpA
Revenue
|
195m
EUR
|
Cost of Revenue
|
-10.7m
EUR
|
Gross Profit
|
184.3m
EUR
|
Operating Expenses
|
-162.9m
EUR
|
Operating Income
|
21.4m
EUR
|
Other Expenses
|
-8.2m
EUR
|
Net Income
|
13.1m
EUR
|
XPR Profitability Score
Profitability Due Diligence
Exprivia SpA's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Exprivia SpA's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
XPR Solvency Score
Solvency Due Diligence
Exprivia SpA's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Score
Exprivia SpA's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
XPR Price Targets Summary
Exprivia SpA
Dividends
Current shareholder yield for XPR is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one XPR stock under the Base Case scenario is 3.46 EUR.
Compared to the current market price of 1.52 EUR, Exprivia SpA is Undervalued by 56%.